Warrants (Details) |
3 Months Ended | 9 Months Ended |
---|---|---|
Sep. 30, 2022
USD ($)
|
Sep. 30, 2022
USD ($)
$ / shares
shares
|
|
Warrants (Details) [Line Items] | ||
Private warrants shares (in Shares) | shares | 8,625,000 | |
Common stock price | $ 10 | |
Warrant price | 0.01 | |
Common stock exceeds price | $ 16.5 | |
Warrant liabilities (in Dollars) | $ | $ 2,242,500 | |
Other income expenses (in Dollars) | $ | $ 603,750 | |
Common stock exercise price | $ 11.5 | |
Private warrants description | The Private Warrants, which are accounted for as liabilities in our condensed consolidated balance sheets, were valued as of September 30, 2022 at $1,906,057 based on their publicly-traded price. The fair value of the Private Warrants was estimated using a Black-Scholes option pricing model using the following assumptions: stock price of $3.61, no assumed dividends, a risk-free rate of 4.06% and implied volatility of 36.7%. The change in value of the Private Warrants during the three months ended September 30, 2022 totaled $(525,839) and was reported with other (income) expense in our condensed consolidated statements of operations. | |
Change in value of SPA Warrants (in Dollars) | $ | $ 7,092,827 | |
Public Warrants [Member] | ||
Warrants (Details) [Line Items] | ||
Common stock price | $ 11.5 | |
Warrant liabilities (in Dollars) | $ | $ 2,242,500 | |
Private Warrants [Member] | ||
Warrants (Details) [Line Items] | ||
Private warrants shares (in Shares) | shares | 7,175,000 | |
Debenture Warrants [Member] | ||
Warrants (Details) [Line Items] | ||
Common stock price | $ 20 | |
Purchase agreement, shares issued (in Shares) | shares | 2,922,425 | |
Warrants expire term | 10 years | 10 years |
Fair value issuance (in Dollars) | $ | $ 28,041,937 | $ 28,041,937 |
X | ||||||||||
- Definition The Common stock exceeds price. No definition available.
|
X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. No definition available.
|
X | ||||||||||
- Definition The private warrants description. No definition available.
|
X | ||||||||||
- Definition The shares of private warrants shares. No definition available.
|
X | ||||||||||
- Definition The purchase agreement, shares issued. No definition available.
|
X | ||||||||||
- Definition The amount paid to Warrant liability. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share decrease in conversion price of convertible common stock. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|